Piramal Pharma Limited — Board Meeting, 28-04-2026: Outcome of Board Meeting

Piramal Pharma's board approved consolidated financial results for the quarter and year ended March 31, 2026. Key re-appointments include Nandini Piramal as Chairperson & ED, Peter DeYoung as ED, and two Independent Directors. Maneesh Sharma appointed new Company Secretary. Registered office address also updated.